Zimbabwe has rejected a substantial US health deal valued at $367m (272 million pounds) spanning five years over the United States' insistence on confidential data.
The decision was revealed following a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa felt the arrangement was "lopsided".
An official representative has since clarified that the US was seeking genetic material for scientific study and profit while was unwilling to guarantee the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable task of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for more dialogue to reach a deal agreeable to all parties so the country's critical HIV programme can continue.
Broader Implications
This development follows a similar case in neighbouring Kenya, where a court blocked a similar health funding agreement following legal challenges were raised about the safety of Kenyans' medical information.
After resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost transparency and accountability.
According to reports, Sixteen African countries have to date signed similar health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no equivalent assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our country would provide the basic resources for medical research with no assurance that the final treatments would be accessible to our population if a new health crisis emerge."
Sovereignty and International Frameworks
He also said that the American exit from the global health body and its push of one-on-one health agreements were undermining structures already set up through the international organization.
Mangwana cited its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.
"This mechanism is designed to guarantee that when a country provides its information, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome continued dialogue with our American counterparts on how subsequent co-operation might be designed in a manner that honours the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that negotiations should continue since much of the nation's HIV programmes relied on external financing.
"In cases where specific concerns arise, such as those relating to information security or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," it said.
The situation highlights the continuing challenges between accepting crucial international aid and protecting national sovereignty in an ever more interconnected world.